Rose Christian

1.3k total citations · 1 hit paper
6 papers, 964 citations indexed

About

Rose Christian is a scholar working on Epidemiology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Rose Christian has authored 6 papers receiving a total of 964 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Epidemiology, 2 papers in Molecular Biology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Rose Christian's work include Liver Disease Diagnosis and Treatment (4 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers) and Fibroblast Growth Factor Research (2 papers). Rose Christian is often cited by papers focused on Liver Disease Diagnosis and Treatment (4 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers) and Fibroblast Growth Factor Research (2 papers). Rose Christian collaborates with scholars based in United States, Germany and Sweden. Rose Christian's co-authors include Yi Luo, Edgar D. Charles, Brent A. Neuschwander‐Tetri, Sudeep Kundu, Rohit Loomba, Arun J. Sanyal, Dina Halegoua‐DeMarzio, Eric Lawitz, Stephen A. Harrison and Manal F. Abdelmalek and has published in prestigious journals such as The Lancet, Scientific Reports and CHEST Journal.

In The Last Decade

Rose Christian

6 papers receiving 945 citations

Hit Papers

Pegbelfermin (BMS-986036), a PEGylated fibroblast growth ... 2018 2026 2020 2023 2018 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2a trial
    2018 424 citations Arun J. Sanyal, Edgar D. Charles et al. The Lancet profile →

Peers

Rose Christian
Pierre Broqua France
Kunimaro Furuta Japan
Makoto Naito Japan
Victoria L. Gadd United Kingdom
Varinder Athwal United Kingdom
Anne T. Schneider Germany
K. Masuda Japan
Stephen A. Hoang United States
Ilaria Petrai Italy
Leslie E. Rogler United States
Pierre Broqua France
Rose Christian
Citations per year, relative to Rose Christian Rose Christian (= 1×) peers Pierre Broqua

Countries citing papers authored by Rose Christian

Since Specialization
Citations

This map shows the geographic impact of Rose Christian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rose Christian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rose Christian more than expected).

Fields of papers citing papers by Rose Christian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rose Christian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rose Christian. The network helps show where Rose Christian may publish in the future.

Co-authorship network of co-authors of Rose Christian

This figure shows the co-authorship network connecting the top 25 collaborators of Rose Christian. A scholar is included among the top collaborators of Rose Christian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rose Christian. Rose Christian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Karsdal, M.A., Samuel J. Daniels, Signe Holm Nielsen, et al.. (2020). Collagen biology and non‐invasive biomarkers of liver fibrosis. Liver International. 40(4). 736–750. 131 indexed citations
2.
Palmer, Scott M., Laurie D. Snyder, Jamie L. Todd, et al.. (2018). Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial of BMS-986020, a Lysophosphatidic Acid Receptor Antagonist for the Treatment of Idiopathic Pulmonary Fibrosis. CHEST Journal. 154(5). 1061–1069. 138 indexed citations
3.
Sanyal, Arun J., Edgar D. Charles, Brent A. Neuschwander‐Tetri, et al.. (2018). Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2a trial. The Lancet. 392(10165). 2705–2717. 424 indexed citations breakdown →
4.
Luo, Yi, Abdul M. Oseini, Isabelle Gagnon, et al.. (2018). An Evaluation of the Collagen Fragments Related to Fibrogenesis and Fibrolysis in Nonalcoholic Steatohepatitis. Scientific Reports. 8(1). 12414–12414. 57 indexed citations
5.
Charles, Edgar D., Brent A. Neuschwander‐Tetri, Juan P. Frías, et al.. (2018). Pegbelfermin (BMS‐986036), PEGylated FGF21, in Patients with Obesity and Type 2 Diabetes: Results from a Randomized Phase 2 Study. Obesity. 27(1). 41–49. 210 indexed citations
6.
Rosen, Glenn D., Lakshmi Sivaraman, Peter T. W. Cheng, et al.. (2017). LPA1 antagonists BMS-986020 and BMS-986234 for idiopathic pulmonary fibrosis: Preclinical evaluation of hepatobiliary homeostasis. PA1038–PA1038. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pierre Broqua Breakdown of academic impact, for papers by Kunimaro Furuta Breakdown of academic impact, for papers by Makoto Naito Breakdown of academic impact, for papers by Victoria L. Gadd Breakdown of academic impact, for papers by Varinder Athwal Breakdown of academic impact, for papers by Anne T. Schneider Breakdown of academic impact, for papers by K. Masuda Breakdown of academic impact, for papers by Stephen A. Hoang Breakdown of academic impact, for papers by Ilaria Petrai Breakdown of academic impact, for papers by Leslie E. Rogler
Rankless by CCL
2026